Literature DB >> 26017679

Prevalence of Nonalcoholic Fatty Liver Disease and Economy.

Jin-Zhou Zhu1, Yi-Ning Dai2, Yu-Ming Wang3, Qin-Yi Zhou4, Chao-Hui Yu5, You-Ming Li6.   

Abstract

BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a growing health issue around the world. AIM: This study is to investigate whether adult prevalence of NAFLD correlates with national economic status.
METHODS: Literature search on PubMed database was conducted to identify eligible records fully published before September 2014. Gross national income (GNI) per capita was chosen to evaluate national economic status. Pearson coefficient, linear regression, and unpaired t test were performed in the statistical analyses.
RESULTS: Twenty-one population-based surveys (seven in East Asia, five in South Asia, three in Middle East, and six in Europe) were included. The pooled prevalence of NAFLD was 24.24%, and the global prevalence was positively correlated with GNI per capita (r = 0.4782, P = 0.0283). Europe witnessed a higher prevalence (28.04%) than Middle East (12.95%, P = 0.0092) and East Asia (19.24%, P = 0.0083). Male presented a higher prevalence than female (P = 0.019), especially in Europe (P = 0.0132) and in Caucasians (P = 0.0383). Furthermore, male prevalence and rural prevalence individually were correlated with economic status (r = 0.5725, P = 0.0257 and r = 0.7389, P = 0.0060). Lastly, the urban (23.93%) witnessed a higher prevalence than the rural or the urban + rural (12.65%, P = 0.0141) in the countries of GNI per capita <$10,000.
CONCLUSIONS: This study suggested that countries with higher economic status tend to present a higher prevalence of NAFLD. It is believed to provide a distinctive epidemiologic perspective to global situation of NAFLD.

Entities:  

Keywords:  Economy; Epidemiology; Gross national income (GNI) per capita; Nonalcoholic fatty liver disease (NAFLD); Prevalence

Mesh:

Year:  2015        PMID: 26017679     DOI: 10.1007/s10620-015-3728-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  41 in total

1.  Metabolic syndrome and nonalcoholic fatty liver disease in a Spanish population: influence of the diagnostic criteria used.

Authors:  Llorenç Caballería; Guillem Pera; Lluís Rodríguez; Maria Antònia Auladell; Jesús Bernad; Santiago Canut; Pere Torán
Journal:  Eur J Gastroenterol Hepatol       Date:  2012-09       Impact factor: 2.566

2.  Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

Authors:  Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

Review 3.  The global NAFLD epidemic.

Authors:  Rohit Loomba; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-17       Impact factor: 46.802

4.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008.

Authors:  Zobair M Younossi; Maria Stepanova; Mariam Afendy; Yun Fang; Youssef Younossi; Hesham Mir; Manirath Srishord
Journal:  Clin Gastroenterol Hepatol       Date:  2011-03-25       Impact factor: 11.382

5.  Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes.

Authors:  Raika Jamali; Mahmoodreza Khonsari; Shahin Merat; Masoud Khoshnia; Elham Jafari; Alireza Bahram Kalhori; Hassan Abolghasemi; Sedighe Amini; Mahtab Maghsoudlu; Mohammad-Reza Deyhim; Houri Rezvan; Akram Pourshams
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

6.  Prevalence and risk factors for non-alcoholic fatty liver disease among adults in an urban Sri Lankan population.

Authors:  Anuradha S Dassanayake; Anuradhani Kasturiratne; Shaman Rajindrajith; Udaya Kalubowila; Sureka Chakrawarthi; Arjuna P De Silva; Miyuki Makaya; Tetsuya Mizoue; Norihiro Kato; A Rajitha Wickremasinghe; H Janaka de Silva
Journal:  J Gastroenterol Hepatol       Date:  2009-05-19       Impact factor: 4.029

7.  Correlates and heritability of nonalcoholic fatty liver disease in a minority cohort.

Authors:  Lynne E Wagenknecht; Ann L Scherzinger; Elizabeth R Stamm; Anthony J G Hanley; Jill M Norris; Yii-Der I Chen; Michael Bryer-Ash; Steven M Haffner; Jerome I Rotter
Journal:  Obesity (Silver Spring)       Date:  2009-02-19       Impact factor: 5.002

8.  Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome.

Authors:  V Mohan; S Farooq; M Deepa; R Ravikumar; C S Pitchumoni
Journal:  Diabetes Res Clin Pract       Date:  2009-01-24       Impact factor: 5.602

9.  Fasting time and lipid parameters: association with hepatic steatosis--data from a random population sample.

Authors:  Martin Gruchot; Tilmann Graeter; Suemeyra Oeztuerk; Mark Martin Haenle; Wolfgang Koenig; Armin Imhof; Bernhard Otto Boehm; Richard Andrew Mason; Wolfgang Kratzer; Atilla Serif Akinli
Journal:  Lipids Health Dis       Date:  2014-01-22       Impact factor: 3.876

10.  Regional prevalence of non-alcoholic fatty liver disease in Seoul and Gyeonggi-do, Korea.

Authors:  Eun Haeng Jeong; Dae Won Jun; Yong Kyun Cho; Young Gil Choe; Seungho Ryu; Seung Min Lee; Eun Chul Jang
Journal:  Clin Mol Hepatol       Date:  2013-09-30
View more
  37 in total

1.  Independent markers of nonalcoholic fatty liver disease in a gentrifying population-based Chinese cohort.

Authors:  Xianghai Zhou; Yufeng Li; Xiuying Zhang; Ying Ying Guan; Yindra Puentes; Fang Zhang; Elizabeth K Speliotes; Linong Ji
Journal:  Diabetes Metab Res Rev       Date:  2019-04-17       Impact factor: 4.876

2.  Managing non-alcoholic fatty liver disease.

Authors:  Jing Hieng Ngu; George Boon Bee Goh; Zhongxian Poh; Roy Soetikno
Journal:  Singapore Med J       Date:  2016-07       Impact factor: 1.858

3.  Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: a case-control study.

Authors:  Jinzhou Zhu; Xingyong Wan; Yuming Wang; Kefu Zhu; Chunxiao Li; Chaohui Yu; Youming Li
Journal:  Endocrine       Date:  2016-09-14       Impact factor: 3.633

4.  The measurement of liver fat from single-energy quantitative computed tomography scans.

Authors:  Xiaoguang Cheng; Glen M Blake; J Keenan Brown; Zhe Guo; Jun Zhou; Fengzhe Wang; Liqiang Yang; Xiaohong Wang; Li Xu
Journal:  Quant Imaging Med Surg       Date:  2017-06

Review 5.  Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral-liver axis.

Authors:  Ryutaro Kuraji; Satoshi Sekino; Yvonne Kapila; Yukihiro Numabe
Journal:  Periodontol 2000       Date:  2021-10       Impact factor: 7.589

Review 6.  Role of Ca2+ channels in non-alcoholic fatty liver disease and their implications for therapeutic strategies (Review).

Authors:  Xingyue Chen; Li Zhang; Liming Zheng; Biguang Tuo
Journal:  Int J Mol Med       Date:  2022-07-07       Impact factor: 5.314

7.  Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case-control study.

Authors:  Jin-Zhou Zhu; Hua-Tuo Zhu; Yi-Ning Dai; Chun-Xiao Li; Zhi-Yun Fang; De-Jian Zhao; Xing-Yong Wan; Yu-Ming Wang; Fang Wang; Chao-Hui Yu; You-Ming Li
Journal:  Endocrine       Date:  2015-09-11       Impact factor: 3.633

Review 8.  Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Valerio Nobili; Anna Alisi; Kimberly P Newton; Jeffrey B Schwimmer
Journal:  Gastroenterology       Date:  2016-03-19       Impact factor: 22.682

Review 9.  Natural History of Nonalcoholic Fatty Liver Disease.

Authors:  George Boon-Bee Goh; Arthur J McCullough
Journal:  Dig Dis Sci       Date:  2016-03-22       Impact factor: 3.199

10.  Efficacy of orlistat in non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Authors:  Hu Wang; Li Wang; Yujia Cheng; Zhiqing Xia; Yifeng Liao; Jiang Cao
Journal:  Biomed Rep       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.